RedHill Biopharma Ltd. (RDHL)

RedHill Biopharma Revenue

RedHill Biopharma had revenue of $1.29M in the quarter ending June 30, 2024, a decrease of -28.40%. This brings the company's revenue in the last twelve months to $3.71M, down -89.63% year-over-year. In the year 2023, RedHill Biopharma had annual revenue of $6.53M, down -89.43%.

• Revenue (ttm): $3.71M
• Revenue Growth: -89.63%
• P/S Ratio: 1.01
• Revenue / Employee: $69,943
• Employees: 53
• Market Cap: 6.10M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	6.53M	-55.27M	-89.43%
Dec 31, 2022	61.80M	-23.96M	-27.94%
Dec 31, 2021	85.76M	21.40M	33.25%
Dec 31, 2020	64.36M	58.07M	923.03%
Dec 31, 2019	6.29M	-2.07M	-24.75%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.